Cost-Effectiveness of Intervention Thresholds for the Treatment of Osteoporosis Based on FRAX® in Portugal
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Cost-Effectiveness of Intervention Thresholds for the Treatment of Osteoporosis Based on FRAX® in Portugal
Authors
Keywords
Cost-effectiveness, FRAX, Intervention thresholds, Osteoporosis, 10-year fracture probability
Journal
CALCIFIED TISSUE INTERNATIONAL
Volume 99, Issue 2, Pages 131-141
Publisher
Springer Nature
Online
2016-03-25
DOI
10.1007/s00223-016-0132-8
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Methods for the estimation of the National Institute for Health and Care Excellence cost-effectiveness threshold
- (2015) Karl Claxton et al. HEALTH TECHNOLOGY ASSESSMENT
- Cost-effective osteoporosis treatment thresholds in Greece
- (2015) P. Makras et al. OSTEOPOROSIS INTERNATIONAL
- The burden of osteoporotic hip fractures in Portugal: costs, health related quality of life and mortality
- (2015) A. Marques et al. OSTEOPOROSIS INTERNATIONAL
- Clinician’s Guide to Prevention and Treatment of Osteoporosis
- (2014) F. Cosman et al. OSTEOPOROSIS INTERNATIONAL
- The incidence of a first major osteoporotic fracture in Iceland and implications for FRAX
- (2014) K. Siggeirsdottir et al. OSTEOPOROSIS INTERNATIONAL
- Cost-Effectiveness of Different Screening Strategies for Osteoporosis in Postmenopausal Women
- (2013) Smita Nayak et al. ANNALS OF INTERNAL MEDICINE
- Comparative cost-effectiveness of bazedoxifene and raloxifene in the treatment of postmenopausal osteoporosis in Europe, using the FRAX algorithm
- (2013) K. Kim et al. OSTEOPOROSIS INTERNATIONAL
- A systematic review of models used in cost-effectiveness analyses of preventing osteoporotic fractures
- (2013) L. Si et al. OSTEOPOROSIS INTERNATIONAL
- EQ-5D Portuguese population norms
- (2013) Lara Noronha Ferreira et al. QUALITY OF LIFE RESEARCH
- Osteoporosis in the European Union: medical management, epidemiology and economic burden
- (2013) E. Hernlund et al. Archives of Osteoporosis
- 2012 update of French guidelines for the pharmacological treatment of postmenopausal osteoporosis
- (2012) Karine Briot et al. JOINT BONE SPINE
- An economic evaluation: Simulation of the cost-effectiveness and cost-utility of universal prevention strategies against osteoporosis-related fractures
- (2012) Léon Nshimyumukiza et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Intervention thresholds for denosumab in the UK using a FRAX®-based cost-effectiveness analysis
- (2012) O. Ström et al. OSTEOPOROSIS INTERNATIONAL
- Cost-effective intervention thresholds against osteoporotic fractures based on FRAX® in Switzerland
- (2012) K. Lippuner et al. OSTEOPOROSIS INTERNATIONAL
- European guidance for the diagnosis and management of osteoporosis in postmenopausal women
- (2012) J. A. Kanis et al. OSTEOPOROSIS INTERNATIONAL
- A systematic review of hip fracture incidence and probability of fracture worldwide
- (2012) J. A. Kanis et al. OSTEOPOROSIS INTERNATIONAL
- Interpretation and use of FRAX in clinical practice
- (2011) J. A. Kanis et al. OSTEOPOROSIS INTERNATIONAL
- Final results of the DAPS (Denosumab Adherence Preference Satisfaction) study: a 24-month, randomized, crossover comparison with alendronate in postmenopausal women
- (2011) N. Freemantle et al. OSTEOPOROSIS INTERNATIONAL
- Potential Clinical and Economic Impact of Nonadherence with Osteoporosis Medications
- (2010) Mickaël Hiligsmann et al. CALCIFIED TISSUE INTERNATIONAL
- Cost-effectiveness of bazedoxifene incorporating the FRAX® algorithm in a European perspective
- (2010) F. Borgström et al. OSTEOPOROSIS INTERNATIONAL
- Cost-effectiveness of Denosumab for the treatment of postmenopausal osteoporosis
- (2010) B. Jönsson et al. OSTEOPOROSIS INTERNATIONAL
- Denosumab for Prevention of Fractures in Postmenopausal Women with Osteoporosis
- (2009) Steven R. Cummings et al. NEW ENGLAND JOURNAL OF MEDICINE
- The cost-effectiveness of risedronate in the UK for the management of osteoporosis using the FRAX®
- (2009) F. Borgström et al. OSTEOPOROSIS INTERNATIONAL
- Differences in persistence, safety and efficacy of generic and original branded once weekly bisphosphonates in patients with postmenopausal osteoporosis: 1-year results of a retrospective patient chart review analysis
- (2009) Johann D. Ringe et al. RHEUMATOLOGY INTERNATIONAL
- Hip fractures cluster in space: an epidemiological analysis in Portugal
- (2008) M. F. de Pina et al. OSTEOPOROSIS INTERNATIONAL
- Cost-effective osteoporosis treatment thresholds: the United States perspective
- (2008) A. N. A. Tosteson et al. OSTEOPOROSIS INTERNATIONAL
- FRAX™ and the assessment of fracture probability in men and women from the UK
- (2008) J. A. Kanis et al. OSTEOPOROSIS INTERNATIONAL
- Case finding for the management of osteoporosis with FRAX®—assessment and intervention thresholds for the UK
- (2008) J. A. Kanis et al. OSTEOPOROSIS INTERNATIONAL
- The NICE Cost-Effectiveness Threshold
- (2008) Christopher McCabe et al. PHARMACOECONOMICS
- The cost-effectiveness of alendronate in the management of osteoporosis
- (2007) John A. Kanis et al. BONE
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now